? FDA Accepts Protocol for Adding an Open-Label Extension to CytoDyn’s Phase 3 Trial for Severe-to-Critical COVID-19 Patients
Anyone heard of a company getting an open - label extension after phase 3 . Then not get approved ????
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-